The new direct target-specific oral anticoagulants (TSOACs; dabigatran, rivaroxaban, apixaban, and edoxaban) have been compared with vitamin K antagonists (VKAs; warfarin and similar agents) for acute venous thromboembolism (VTE) in six recent phase III clinical trials encompassing more than 27,000…
Read MoreIn a recent retrospective study from Mayo Clinic, researchers demonstrated that intravenous contrast material was not associated with acute kidney injury (i.e., increase in serum creatinine level of ≥0.5 mg/dL) during the 72 hours after computed tomography (CT) of the…
Read MoreAdvise patients to drink at least 2 L daily; consider thiazide diuretics, citrate therapy and allopurinol for patients with “active” calcium stone formation. American College of Physicians (ACP) Key Recommendations Increased fluid intake to achieve 2 L of urine output daily…
Read MoreIn a new meta-analysis, early management of non–ST-segment elevation myocardial infarctions with thienopyridines was not associated with significantly lower mortality and did not lower major adverse cardiovascular event rates for those eventually undergoing PCI. Current ACC/AHA guidelines support dual antiplatelet…
Read MoreThe American Heart Association/American Stroke Association has updated its comprehensive acute ischemic stroke care guidelines in 2013. The following is a summary of the most important new recommendations: Teleradiology networks are recommended for community hospitals that lack access to neurological…
Read MoreCardiac arrest patients who were intubated had similar outcomes to those who had a supraglottic airway device (e.g., King tube) inserted in the pre-hospital setting. A literature review of 5 studies and over 300,000 patients with pre-hospital cardiac arrest demonstrated…
Read MoreTranexamic acid is a simple little molecule, just a synthetic derivative of the amino acid lysine. But it’s also a potent pro-hemostatic drug that binds plasminogen and plasmin and stops the degradation of fibrin (the stuff in blood clots). Now…
Read MoreCompared with warfarin, the new agents significantly reduced all-cause and vascular mortality. The new direct-acting oral anticoagulants (DOACs; dabigatran, rivaroxaban, apixaban, and edoxaban) have been found to be noninferior to vitamin K antagonists in clinical trials of stroke prevention in…
Read MoreCategories
- ACLS (1)
- Arterial line (33)
- Cardiovascular diseases (77)
- Central line (55)
- Chest Tube (39)
- Dermatology (4)
- Emergency Procedures (138)
- Endocrinology (6)
- Endotracheal Intubation (36)
- Events (24)
- FAST Exam (12)
- Featured (112)
- Featured Procedure (42)
- Gastrointestinal diseases (32)
- Ginecology (3)
- Glidescope Intubation (21)
- Hematology (33)
- Hospital Procedures (85)
- Infections (32)
- Intraosseous line (8)
- King Tube (27)
- Laryngeal Mask Airway (18)
- Lumbar Puncture (36)
- Mechanical Ventilation (34)
- Medical General (95)
- medical procedures (258)
- Needle Decompression (6)
- Nephrology (11)
- Neurological diseases (12)
- Oncology (4)
- Paracentesis (32)
- Pericardiocentesis (3)
- Procedural Sedation (19)
- Respiratory diseases (85)
- RUSH Exam (8)
- Thoracentesis (37)
- Traumatology (24)
- Travel (27)
- Ultrasound-Guided Peripheral IV (13)